BPC 157 can be taken orally or subcutaneously, and for most people there is no difference in efficacy.Yes, some people will notice one works better than the other. Yes, some people will claim that The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Proposes Exclusion of Semaglutide, Tirzepatide, Liraglutide from 503B Bulks List FDA posted on the topic LinkedIn People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian BPC 157 Fierce Longevity Pricing Prairie State Health & Wellness